Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Software
/
Cellebrite DI
CLBT
Cellebrite DI
Digital Device Growth And Cybercrime Will Transform Investigations
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
22 Aug 25
Updated
22 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$28.00
42.5% undervalued
intrinsic discount
22 Aug
US$16.11
Loading
1Y
-6.1%
7D
3.3%
Author's Valuation
US$28.0
42.5% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$28.0
42.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-317m
730m
2019
2021
2023
2025
2027
2028
Revenue US$729.5m
Earnings US$201.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
14.25%
Software revenue growth rate
1.48%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
10.67%
Calculation
US$201.14m
Earnings '28
x
56.38x
PE Ratio '28
=
US$11.34b
Market Cap '28
US$11.34b
Market Cap '28
/
299.49m
No. shares '28
=
US$37.87
Share Price '28
US$37.87
Share Price '28
Discounted to 2025 @ 10.65% p.a.
=
US$27.95
Fair Value '25